Bio-Techne Corporation reported earnings results for the third quarter and nine months ended March 31, 2024. For the third quarter, the company reported sales was USD 303.43 million compared to USD 294.15 million a year ago. Net income was USD 49.06 million compared to USD 70.22 million a year ago. Basic earnings per share from continuing operations was USD 0.31 compared to USD 0.45 a year ago. Diluted earnings per share from continuing operations was USD 0.31 compared to USD 0.43 a year ago.
For the nine months, sales was USD 852.96 million compared to USD 835.38 million a year ago. Net income was USD 127.52 million compared to USD 209.78 million a year ago. Basic earnings per share from continuing operations was USD 0.81 compared to USD 1.34 a year ago. Diluted earnings per share from continuing operations was USD 0.79 compared to USD 1.3 a year ago.